Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aigo.ai is a technology company that develops a sophisticated 'Integrated Cognitive AI' platform designed to provide highly personalized and context-aware conversational assistants. Unlike traditional chatbots, Aigo's technology utilizes a cognitive engine that features short-term and long-term memory, enabling it to learn from interactions and maintain complex, multi-turn conversations. In the healthcare sector, the company provides intelligent virtual assistants that support patient engagement, medication adherence, and personalized health coaching. By leveraging its proprietary 'Third Generation AI' architecture, Aigo.ai aims to deliver human-like interaction capabilities to large-scale healthcare providers and pharmaceutical companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aigo.